[1] PICKERING T G.Renal artery disease[M]//TOPOL E J. Text book of cardiovascular medicine.Philadelphia:Lippincott-Raven,1998:98.
[2] PLOUIN P F, BAX L.Diagnosis and treatment of renal artery stenosis[J].Nat Rev Nephrol,2010,6(3):151-159.
[3] JAZRAWI A, DARDA S,BURKE P,et al.Is race a risk factor for the development of renal artery stenosis?[J].Cardiol Res Pract,2009,2009:817987.
[4] KRIJNEN P,van JAARSVELD B C,DEINUM J,et al.Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention?[J].J Hum Hypertens,2004,18(2):91-96.
[5] CHRYSOCHOU C, KALRA P A.Current management of atherosclerotic renovascular disease-what have we learned from ASTRAL?[J].Nephron Clin Pract,2010,115(1):c73-c81.
[6] 左智,马根山.动脉粥样硬化性肾动脉狭窄的诊断与治疗[J].现代医学,2012,40(3):342-345.
[7] 何厚洪,赵开银,罗孝勇,等.彩色多普勒超声对肾动脉狭窄的诊断价值[J].西部医学,2012,24(7):1366-1367,1369.
[8] 董蓓莉,侯效民.正常人肾动脉内径和血流参数的超声测量[J].杭州医学高等专科学校学报,1994,3(1):1-3.
[9] 黄中敏,谢汝明.碘造影剂肾病的危险因素、预防及护理[J].齐鲁护理杂志,2012,18(34):42-45.
[10] REDDAN D,FISHMAN E K.Radiologists knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists[J].Eur J Ra,2008,66:235-245.
[11] KUHN M J,CHEN N,SSHANI D V,et al.The PRDICT study:a randomized double-blind comparison of contrast-induced nepropathy after low-or iso-osmolar contrast agent exposure[J].AJR Am J Roentgenol,2008,181:151-157. |